NCT03792061Active, not recruiting
Enhancing Community Participation for Stroke Survivors With Cognitive Impairments
Adopting Strategy Training to Improve Participation Performance of Individuals With Cognitive Impairments After Stroke
Source: ClinicalTrials.gov · Last updated 20 Nov 2024
Brief summary (registry, in English)
Abstract Method: Participants with a diagnosis of stroke and have cognitive impairment (a score of 3 or more on the Executive Interview, 14-item version) will be randomly assigned to the intervention group and the attention control group at a 1:1 ratio. Each session will be around 45 minutes and will be delivered 1 to 2 sessions per week for 12 to 15 sessions. Outcome measures including the Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D), Canadian Occupational Performance Measure(COPM), Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms, Wisconsin Card Sorting Task (WCST), Stroop Test, Montreal Cognitive Assessment (MoCA), Trail-Making Test (TMT A and B), The National Institutes of Health Stroke scale (NIHSS), modified Rankin Scale (MRS), Euro-QoL-5-Dimension (EQ-5D) and Participation Strategies Self Efficacy Scale (PS-SES) will be administered at baseline (T1), post-intervention (T2), 3-month follow-up (T3), 6-month follow-up (T4), and 12-month follow-up (T5). Of the recruited participants, 50 will recieve the fMRI tests (including the resting-state scan, the fMRI scan with Stroop Test and TMT tasks, and the anatomical structure scan) at baseline, post-intervention, and 6month follow-up.Data will be analyzed using multiple linear regression models and mixed-effects regression models.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 210 (actual)
- First submitted
- 1 Jan 2019
- Start date
- 13 Jan 2019
- Primary completion date
- 22 Aug 2024
- Lead sponsor
- Taipei Medical University
- Diseases
- Stroke
- NCT number
- NCT03792061
What you commit to
- Study type: Interventional
- Participants enrolled: 210
- From 13 Jan 2019 to the primary completion date, 22 Aug 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have a pre-stroke diagnosis of dementia, current major depressive disorder, substance use, or other psychiatric disorders that may impede them from continually participating in the study.
Other
- Have severe aphasia
Who the study is looking for
- Ages 20 years and older
- Has a diagnosis of stroke
- Understand Mandarin
- Has cognitive impairment (a score of 3 or more on the Executive Interview, 14-item version)
- Provide informed consent
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taipei Medical University Shuang Ho Hospital Coordinator of this site? Confirm its status | New Taipei City | Taiwan | Unknown status |
| Taipei Medical University Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| Taipei Municipal Wan Fang Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
Related publications
- Effect of participation-focused strategy training on post-stroke cognitive functions and quality of life: results from a randomized trial.Ann Phys Rehabil Med · 2026 · PMID 42013638
This page is information, not medical advice. Discuss any trial with your doctor.